Vinburnine
Compound once marketed to improve brain circulation (Cervoxan); it widens brain vessels, but modern large human trials are lacking.
Pharmacology
Contents
DETAILED OVERVIEW
What is Vinburnine?
Vinburnine is a compound of the vinca alkaloid family, known from periwinkle plants, that was used as a medicine to improve circulation in the brain, for example in France under the name Cervoxan. In several countries it has since been withdrawn or restricted, and it is not approved in the United States.
By widening the blood vessels of the brain it may improve blood flow and oxygen supply and make nerve tissue more resistant to a lack of oxygen. In experimental models learning and memory problems improved, and a supportive effect on thinking has been described in older adults. The evidence comes mostly from animal studies and older clinical observations; modern large comparative trials are lacking. Because it widens vessels it can cause dizziness and a drop in blood pressure, and together with blood-pressure medicines this may add up. Safety in pregnancy and breastfeeding has not been established.
Mechanism
Cerebral vasodilation + PDE modulation
Half-life
Short, a few hours (like related vinca alkaloids)
Legal status
Medicine in some markets (Cervoxan), not FDA-approved
No anecdote collected yet.
Receptor profile
- Phosphodiesterase (PDE)Moderate
- Cerebral blood flowModerate
- Muscarinic acetylcholine receptors (allosteric)Moderate
- Neuronal metabolism / antihypoxiaWeak
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Dizziness, particularly on standing due to lowered blood pressure
- Low blood pressure (hypotension) from the vasodilatory effect
- Occasional gastrointestinal upset, nausea
- Rare skin reactions: fixed drug eruption reported in a case report
- Limited safety data from large clinical trials
Contraindications · 4
- Pregnancy and breastfeeding: safety not established, avoid
- Low blood pressure or hypotension tendency: the vasodilatory effect may worsen it
- Co-administration with other blood-pressure-lowering agents: additive hypotension
- Known hypersensitivity to vinca alkaloids or the compound
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Eburnamine derivatives and the brain
Zsilla G, Vizi ES
Effects of vinburnine on experimental models of learning and memory impairments
Nemeth EF, Fejes-Toth AN, et al.
Vinburnine decelerates [3H]N-methylscopolamine binding to recombinant human muscarinic M1-M4 acetylcholine receptors
Tuček S, et al.
Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors
Jakubík J, Tuček S
Red blood cell metabolism and hemoglobin oxygen affinity. Effect of vinburnine on normobaric hypoxic rats
Fiorani M, et al.
[The effects of the acute administration of vinburnine on blood rheology, oxygen transport and regional circulation under normal conditions and in hypoxemia. In vivo research]
et al.
FAQ
FAQ
Vinburnine was traditionally used to improve cerebral blood flow (marketed in France as Cervoxan), aiming to widen brain blood vessels and boost oxygen delivery, which in turn helps protect nerve cells from low-oxygen stress. It was mainly described for cognitive support in older adults, and experimental studies showed improvements in learning and memory problems, though real-world data on it today are limited.
Telegram
Have a question about Vinburnine?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.